Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for Cardiac Function After TAVR
NCT06196177Phase 4Unknown
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Mar 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in heart failure (HF), sponsored by Qilu Hospital of Shandong University. Status: unknown.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06196177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06196177.